ACT1 Stock Overview

Develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. More details

ACT1 fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	4/6
Past Performance	6/6
Financial Health	6/6
Dividends	2/6

Rewards

Trading at 51.3% below our estimate of its fair value

Earnings are forecast to grow 13.24% per year

Earnings grew by 56.2% over the past year

Risk Analysis

Shares are highly illiquid

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

AlzChem Group AG Competitors

AMAG Austria Metall

WBAG:AMAG

€952.1m

Mayr-Melnhof Karton

WBAG:MMK

€1.7b

Wienerberger

WBAG:WIE

€3.8b

Anupam Rasayan India

NSEI:ANURAS

₹84.5b

Price History & Performance

Summary of share price highs, lows and changes for AlzChem Group
Historical stock prices
Current Share Price	€96.40
52 Week High	€96.40
52 Week Low	€88.80
Beta	1
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	2.34%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ACT1	AT Chemicals	AT Market
7D	n/a	-3.1%	-0.9%
1Y	n/a	-7.6%	16.1%

Return vs Industry: Insufficient data to determine how ACT1 performed against the Austrian Chemicals industry.

Return vs Market: Insufficient data to determine how ACT1 performed against the Austrian Market.

Price Volatility

Is ACT1's price volatile compared to industry and market?
ACT1 volatility
ACT1 Average Weekly Movement	n/a
Chemicals Industry Average Movement	5.0%
Market Average Movement	4.3%
10% most volatile stocks in AT Market	8.3%
10% least volatile stocks in AT Market	2.5%

Stable Share Price: ACT1's share price has been volatile over the past 3 months compared to the Austrian market.

Volatility Over Time: Insufficient data to determine ACT1's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1908	1,647	Andreas Niedermaier	www.alzchem.com

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries.

AlzChem Group AG Fundamentals Summary

How do AlzChem Group's earnings and revenue compare to its market cap?
ACT1 fundamental statistics
Market cap	€984.62m
Earnings (TTM)	€54.08m
Revenue (TTM)	€563.44m

18.2x

P/E Ratio

1.7x

P/S Ratio

Is ACT1 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACT1 income statement (TTM)
Revenue	€563.44m
Cost of Revenue	€214.97m
Gross Profit	€348.47m
Other Expenses	€294.40m
Earnings	€54.08m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Apr 30, 2025

Earnings per share (EPS)	5.33
Gross Margin	61.85%
Net Profit Margin	9.60%
Debt/Equity Ratio	23.5%

How did ACT1 perform over the long term?

See historical performance and comparison

Dividends

1.9%

Current Dividend Yield

34%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/03/25 08:57
End of Day Share Price	2025/03/24 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

AlzChem Group AG is covered by 7 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Volker Bosse	Baader Helvea Equity Research
Konstantin Wiechert	Baader Helvea Equity Research
Gerhard Orgonas	Berenberg